SEC EDGAR Filing Information

Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]

Filing Date Changed: 2008-02-13
Documents: 1

SEC Accession No.
0000950162-08-000097
Filing date: 2008-02-13
Accepted: 2008-02-13 15:34:02

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G/A	dorsigtaupharm13gano1_021308.htm	227514	DOR BIOPHARMA INC. - SIGMA TAU PHARMACEUTICALS SCHEDULE 13G/A NO. 1

		0000950162-08-000097.txt	229675	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Subject) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 08604332
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628

Sigma-Tau Pharmaceuticals, Inc. (Filed by) (0001385625)
IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: | Film No.:

Business Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877
1-800-447-0169

Mailing Address
800 SOUTH FREDERICK AVENUE
SUITE 300
GAITHERSBURG MD 20877